Supplementary Materials and Methods from Design and Preclinical Evaluation of a Novel B7-H4–Directed Antibody–Drug Conjugate, AZD8205, Alone and in Combination with the PARP1-Selective Inhibitor AZD5305
Authors:
- Krista KinneerKKKrista Kinneer
- Philipp WortmannPWPhilipp Wortmann
- Zachary A. CooperZCZachary A. Cooper
- Niall J. DickinsonNDNiall J. Dickinson
- Luke MastersonLMLuke Masterson
- Thais CailleauTCThais Cailleau
- Ian HutchinsonIHIan Hutchinson
- Balakumar VijayakrishnanBVBalakumar Vijayakrishnan
- Mary McFarlaneMMMary McFarlane
- Kathryn BallKBKathryn Ball
- Michael DaviesMDMichael Davies
- Arthur LewisALArthur Lewis
Open Access
- 25 November 2025
- other
- Published by American Association for Cancer Research (AACR)